Andrew Chang and Steven Falcone, Novo Nordisk, discuss GMP mutual recognition, real-time digital monitoring, and the future of pharma QMS.
Andrew Chang
Advertisement
Senior Director for Quality and Regulatory Affairs in Science, Policy, and Intelligence under Global Regulatory Affairs, Novo Nordisk
Articles by Andrew Chang
Andrew Chang and Steven Falcone, Novo Nordisk, share how real-time digital monitoring, smart sensors, and a globally connected manufacturing network are shaping pharma's QMS future.
Andrew Chang and Steven Falcone, Novo Nordisk, explain how FDA-EU GMP mutual recognition and a robust internal signal process drive global regulatory compliance.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Q&A: Why Pharma Deal Volume Is Down but Value Is Up
5